CRISM Telemedicine Support for Addiction Services Guidance Document:
The following questions are related to your use of telemedicine and the rapid guidance document
Please indicate where you have received information on CRISM's Rapid Telemedicine Support for Addiction Services Guidance Document *
Your answer
Prior to the dissemination of CRISM’s Telemedicine Support for Addiction Services rapid guidance document, have you used or practised telemedicine? *
Prior to the dissemination of CRISM’s Telemedicine Support for Addiction Services rapid guidance document, have you ever used or practised telemedicine for Opioid Agonist Therapy (OAT)? *
In the past year, please indicate how frequently you have used the following to access or provide health services?